FindTrial
Sign In

Liver Transplant Mortality Prediction for Benign End-stage Liver Diseases

Liver Transplant Mortality Prediction for Benign End-stage Liver Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068692
Enrollment
Unknown
Registered
2023-02-27
Start date
2021-12-15
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver transplantation

Interventions

Training group:None
validation group:None

Sponsors

First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients 18 years of age and older (2) the presence of benign end-stage liver disease (3) underwent LT.

Exclusion criteria

Exclusion criteria: (1) less than 18 years old (2) diagnosed with hepatocellular carcinoma before LT (3) underwent a multi-visceral transplant, split transplant or living donor transplant.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactTingbo Liang

First Affiliated Hospital, Zhejiang University School of Medicine

liangtingbo@zju.edu.cn+86 571 87236736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026